NightHawk Biosciences (NHWK)

NightHawk Biosciences (NHWK) Stock Price & Analysis


NHWK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.65 - $3.42
Previous Close$0.69
Average Volume (3M)42.82K
Market Cap
Enterprise Value-$3.17M
Total Cash (Recent Filing)$28.64M
Total Debt (Recent Filing)$9.10M
Price to Earnings (P/E)-0.4
Aug 09, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.87
Shares Outstanding26,049,209
10 Day Avg. Volume55,642
30 Day Avg. Volume42,818
Standard Deviation0.32
Financial Highlights & Ratios
Price to Book (P/B)0.35
Price to Sales (P/S)23.12
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.46
Enterprise Value/Gross Profit1.07
Enterprise Value/Ebitda0.06
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was NightHawk Biosciences’s price range in the past 12 months?
NightHawk Biosciences lowest stock price was $0.65 and its highest was $3.42 in the past 12 months.
    What is NightHawk Biosciences’s market cap?
    Currently, no data Available
    When is NightHawk Biosciences’s upcoming earnings report date?
    NightHawk Biosciences’s upcoming earnings report date is Aug 09, 2023 which is in 66 days.
      How were NightHawk Biosciences’s earnings last quarter?
      Currently, no data Available
      Is NightHawk Biosciences overvalued?
      According to Wall Street analysts NightHawk Biosciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does NightHawk Biosciences pay dividends?
        NightHawk Biosciences does not currently pay dividends.
        What is NightHawk Biosciences’s EPS estimate?
        NightHawk Biosciences’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does NightHawk Biosciences have?
        NightHawk Biosciences has 26,049,210 shares outstanding.
          What happened to NightHawk Biosciences’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of NightHawk Biosciences?
          Currently, no hedge funds are holding shares in NHWK


          NightHawk Biosciences Stock Smart Score

          This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
          Learn more about TipRanks Smart Score

          Company Description

          NightHawk Biosciences

          Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.


          Top 5 ETFs holding NHWK

          Market Value
          Smart Score
          iShares Core S&P Total U.S. Stock Market ETF
          Up to five ETFs with an Outperform Smart Score that hold NHWK. The ETFs are listed according to market value of NHWK within the ETF


          Forecast EPS vs Actual EPS

          Currently, no data available
          Please return soon. This page is being updated.

          Similar Stocks
          Price & Change
          TRACON Pharmaceuticals
          Monopar Therapeutics Inc
          Eledon Pharmaceuticals
          Diamedica Therapeutics

          Popular Stocks

          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis